TreeWAS – Variant ID: rs11101442

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z36.9 Antenatal screening, unspecified	0.080	0.920	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.032	0.968	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.031	0.969	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.030	0.969	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.028	0.972	0.000
T46.1 Calcium-channel blockers	0.025	0.974	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.025	0.975	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.023	0.977	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.023	0.977	0.000
T46.7 Peripheral vasodilators	0.023	0.977	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.023	0.977	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.023	0.977	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.021	0.979	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.021	0.979	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.021	0.979	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.018	0.982	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.017	0.983	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.017	0.983	0.000
T50.1 Loop [high-ceiling] diuretics	0.017	0.983	0.000
T36 Poisoning by systemic antibiotics	0.017	0.983	0.000
T40.4 Other synthetic narcotics	0.017	0.983	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.017	0.983	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.016	0.984	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.016	0.984	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.016	0.984	0.000
T50.4 Drugs affecting uric acid metabolism	0.016	0.984	0.000
T50.7 Analeptics and opioid receptor antagonists	0.015	0.985	0.000
T50.5 Appetite depressants	0.015	0.985	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.015	0.985	0.000
T50.0 Mineralocorticoids and their antagonists	0.015	0.985	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.015	0.985	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.015	0.985	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.015	0.985	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.015	0.985	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.015	0.985	0.000
F00 Dementia in Alzheimer's disease	0.014	0.986	0.000
T36.0 Penicillins	0.014	0.986	0.000
T40.1 Heroin	0.014	0.986	0.000
T40.5 Cocaine	0.013	0.987	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.013	0.987	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.013	0.987	0.000
F03 Unspecified dementia	0.013	0.987	0.000
T47.4 Other laxatives	0.013	0.987	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.013	0.987	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.013	0.987	0.000
T47.7 Emetics	0.013	0.987	0.000
T47.6 Antidiarrhoeal drugs	0.013	0.987	0.000
T47.5 Digestants	0.013	0.987	0.000
T47.3 Saline and osmotic laxatives	0.013	0.987	0.000
T47.2 Stimulant laxatives	0.013	0.987	0.000
T47.0 Histamine H(2)-receptor antagonists	0.013	0.987	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.013	0.987	0.000
K70.3 Alcoholic cirrhosis of liver	0.013	0.987	0.000
T50.8 Diagnostic agents	0.012	0.987	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.012	0.987	0.000
T40.8 Lysergide [LSD]	0.012	0.987	0.000
T40.7 Cannabis (derivatives)	0.012	0.987	0.000
T40.3 Methadone	0.012	0.987	0.000
T40.0 Opium	0.012	0.987	0.000
T40.6 Other and unspecified narcotics	0.012	0.988	0.000
F02 Dementia in other diseases classified elsewhere	0.012	0.988	0.000
T36.9 Systemic antibiotic, unspecified	0.012	0.988	0.000
T36.8 Other systemic antibiotics	0.012	0.988	0.000
T36.7 Antifungal antibiotics, systemically used	0.012	0.988	0.000
T36.6 Rifamycins	0.012	0.988	0.000
T36.5 Aminoglycosides	0.012	0.988	0.000
T36.4 Tetracyclines	0.012	0.988	0.000
T36.3 Macrolides	0.012	0.988	0.000
T36.2 Chloramphenicol group	0.012	0.988	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.012	0.988	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.012	0.988	0.000
T38.9 Other and unspecified hormone antagonists	0.012	0.988	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.012	0.988	0.000
T38.7 Androgens and anabolic congeners	0.012	0.988	0.000
T38.5 Other oestrogens and progestogens	0.012	0.988	0.000
T38.4 Oral contraceptives	0.012	0.988	0.000
T38.2 Antithyroid drugs	0.012	0.988	0.000
T38.0 Glucocorticoids and synthetic analogues	0.012	0.988	0.000
F05.9 Delirium, unspecified	0.012	0.988	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.012	0.988	0.000
T49.9 Topical agent, unspecified	0.012	0.988	0.000
T49.8 Other topical agents	0.012	0.988	0.000
T49.7 Dental drugs, topically applied	0.012	0.988	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.012	0.988	0.000
T49.5 Ophthalmological drugs and preparations	0.012	0.988	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.988	0.000
T49.3 Emollients, demulcents and protectants	0.012	0.988	0.000
T49.2 Local astringents and local detergents	0.012	0.988	0.000
T49.1 Antipruritics	0.012	0.988	0.000
F02.0 Dementia in Pick's disease	0.012	0.988	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.012	0.988	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.011	0.988	0.000
T37.5 Antiviral drugs	0.011	0.988	0.000
T37.4 Anthelminthics	0.011	0.988	0.000
T37.3 Other antiprotozoal drugs	0.011	0.988	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.011	0.988	0.000
T37.1 Antimycobacterial drugs	0.011	0.988	0.000
T37.0 Sulphonamides	0.011	0.988	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.011	0.989	0.000
T41.5 Therapeutic gases	0.011	0.989	0.000
T41.4 Anaesthetic, unspecified	0.011	0.989	0.000
T41.3 Local anaesthetics	0.011	0.989	0.000
T41.2 Other and unspecified general anaesthetics	0.011	0.989	0.000
T41.1 Intravenous anaesthetics	0.011	0.989	0.000
T41.0 Inhaled anaesthetics	0.011	0.989	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.011	0.989	0.000
T48.5 Anti-common-cold drugs	0.011	0.989	0.000
T48.4 Expectorants	0.011	0.989	0.000
T48.3 Antitussives	0.011	0.989	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.011	0.989	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.011	0.989	0.000
T48.0 Oxytocic drugs	0.011	0.989	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.011	0.989	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.011	0.989	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.011	0.989	0.000
T38.1 Thyroid hormones and substitutes	0.010	0.989	0.000
D14.0 Middle ear, nasal cavity and accessory sinuses	0.010	0.990	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.010	0.990	0.000
F09 Unspecified organic or symptomatic mental disorder	0.010	0.990	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.010	0.990	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.009	0.990	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.009	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.009	0.990	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.009	0.990	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.009	0.990	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.009	0.990	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.009	0.990	0.000
T44.0 Anticholinesterase agents	0.009	0.990	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.009	0.991	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.009	0.991	0.000
F02.2 Dementia in Huntington's disease	0.009	0.991	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.009	0.991	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.009	0.991	0.000
F02.3 Dementia in Parkinson's disease	0.009	0.991	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.009	0.991	0.000
F07.2 Postconcussional syndrome	0.009	0.991	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.008	0.992	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.008	0.992	0.000
T45.8 Other primarily systemic and haematological agents	0.008	0.992	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.008	0.992	0.000
T45.6 Fibrinolysis-affecting drugs	0.008	0.992	0.000
T45.4 Iron and its compounds	0.008	0.992	0.000
T45.3 Enzymes, not elsewhere classified	0.008	0.992	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.008	0.992	0.000
T45.2 Vitamins, not elsewhere classified	0.008	0.992	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.992	0.000
F07.0 Organic personality disorder	0.008	0.992	0.000
T45.5 Anticoagulants	0.008	0.992	0.000
F01 Vascular dementia	0.008	0.992	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.008	0.992	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.008	0.992	0.000
F07.1 Postencephalitic syndrome	0.008	0.992	0.000
K31.9 Disease of stomach and duodenum, unspecified	0.000	0.992	0.008
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.008	0.992	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.007	0.992	0.000
F05.1 Delirium superimposed on dementia	0.007	0.993	0.000
T43.6 Psychostimulants with abuse potential	0.007	0.993	0.000
T45.0 Antiallergic and antiemetic drugs	0.007	0.993	0.000
F05.0 Delirium not superimposed on dementia, so described	0.007	0.993	0.000
T39.0 Salicylates	0.007	0.993	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.007	0.993	0.000
T43.9 Psychotropic drug, unspecified	0.007	0.993	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
D86.9 Sarcoidosis, unspecified	0.007	0.993	0.000
F05.8 Other delirium	0.006	0.993	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.006	0.993	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.006	0.994	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.006	0.994	0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.006	0.994	0.000
D14 Benign neoplasm of middle ear and respiratory system	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
T42.4 Benzodiazepines	0.006	0.994	0.000
T42.3 Barbiturates	0.006	0.994	0.000
F01.8 Other vascular dementia	0.006	0.994	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.006	0.994	0.000
F01.2 Subcortical vascular dementia	0.006	0.994	0.000
F01.0 Vascular dementia of acute onset	0.006	0.994	0.000
Z36 Antenatal screening	0.006	0.994	0.000
D86 Sarcoidosis	0.006	0.994	0.000
F01.1 Multi-infarct dementia	0.006	0.994	0.000
I44.7 Left bundle-branch block, unspecified	0.006	0.994	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.006	0.994	0.000
F06.5 Organic dissociative disorder	0.006	0.994	0.000
F06.4 Organic anxiety disorder	0.006	0.994	0.000
F06.3 Organic mood [affective] disorders	0.006	0.994	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.006	0.994	0.000
F06.1 Organic catatonic disorder	0.006	0.994	0.000
F06.0 Organic hallucinosis	0.006	0.994	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.006	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
D14.1 Larynx	0.005	0.995	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.005	0.995	0.000
D14.3 Bronchus and lung	0.005	0.995	0.000
K62.4 Stenosis of anus and rectum	0.000	0.995	0.005
D86.1 Sarcoidosis of lymph nodes	0.005	0.995	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.995	0.000
D86.8 Sarcoidosis of other and combined sites	0.005	0.995	0.000
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.000	0.995	0.005
G30.9 Alzheimer's disease, unspecified	0.005	0.995	0.000
K70 Alcoholic liver disease	0.005	0.995	0.000
D14.4 Respiratory system, unspecified	0.005	0.995	0.000
D14.2 Trachea	0.005	0.995	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.005	0.995	0.000
K70.4 Alcoholic hepatic failure	0.005	0.995	0.000
D86.3 Sarcoidosis of skin	0.005	0.995	0.000
Z36.5 Antenatal screening for isoimmunisation	0.004	0.995	0.000
T42.0 Hydantoin derivatives	0.004	0.995	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.004	0.995	0.000
X78.0 Home	0.004	0.996	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.004	0.996	0.000
F01.9 Vascular dementia, unspecified	0.004	0.996	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.004	0.996	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.004	0.996	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.004	0.996	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.004	0.996	0.000
Z42.0 Follow-up care involving plastic surgery of head and neck	0.004	0.996	0.000
D80-D89 Certain disorders involving the immune mechanism	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
X67.9 Unspecified place	0.004	0.996	0.000
D86.0 Sarcoidosis of lung	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.004	0.996	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.004	0.996	0.000
K70.9 Alcoholic liver disease, unspecified	0.004	0.996	0.000
X78 Intentional self-harm by sharp object	0.003	0.996	0.000
F06.7 Mild cognitive disorder	0.003	0.997	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.003	0.997	0.000
D89.1 Cryoglobulinaemia	0.003	0.997	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.003	0.997	0.000
D84 Other immunodeficiencies	0.003	0.997	0.000
D89.3 Immune reconstitution syndrome	0.003	0.997	0.000
S02.50 Fracture of tooth (closed)	0.003	0.997	0.000
C32.9 Larynx, unspecified	0.003	0.997	0.000
C32.0 Glottis	0.003	0.997	0.000
D81 Combined immunodeficiencies	0.003	0.997	0.000
Z33 Pregnant state, incidental	0.003	0.997	0.000
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.003	0.997	0.000
S70.1 Contusion of thigh	0.003	0.997	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.003	0.997	0.000
C18.6 Descending colon	0.000	0.997	0.003
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.003	0.997	0.000
D82 Immunodeficiency associated with other major defects	0.003	0.997	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.003	0.997	0.000
K25.7 Chronic without haemorrhage or perforation	0.000	0.997	0.003
D83 Common variable immunodeficiency	0.003	0.997	0.000
X67.0 Home	0.003	0.997	0.000
C32 Malignant neoplasm of larynx	0.003	0.997	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.003	0.997	0.000
D80 Immunodeficiency with predominantly antibody defects	0.003	0.997	0.000
K73.9 Chronic hepatitis, unspecified	0.003	0.997	0.000
X60-X84 Intentional self-harm	0.003	0.997	0.000
K92.9 Disease of digestive system, unspecified	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
N64.9 Disorder of breast, unspecified	0.000	0.997	0.003
X78.9 Unspecified place	0.003	0.997	0.000
X78.8 Other specified place	0.003	0.997	0.000
X78.7 Farm	0.003	0.997	0.000
X78.6 Industrial and construction area	0.003	0.997	0.000
X78.5 Trade and service area	0.003	0.997	0.000
X78.4 Street and highway	0.003	0.997	0.000
X78.3 Sports and athletics area	0.003	0.997	0.000
X78.2 School, other institution and public administrative area	0.003	0.997	0.000
X78.1 Residential institution	0.003	0.997	0.000
D84.1 Defects in the complement system	0.003	0.997	0.000
E80.4 Gilbert's syndrome	0.000	0.997	0.003
G25.0 Essential tremor	0.000	0.997	0.003
D84.8 Other specified immunodeficiencies	0.003	0.997	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.003	0.997	0.000
X67.8 Other specified place	0.003	0.997	0.000
X67.7 Farm	0.003	0.997	0.000
X67.6 Industrial and construction area	0.003	0.997	0.000
X67.5 Trade and service area	0.003	0.997	0.000
X67.4 Street and highway	0.003	0.997	0.000
X67.3 Sports and athletics area	0.003	0.997	0.000
X67.2 School, other institution and public administrative area	0.003	0.997	0.000
X67.1 Residential institution	0.003	0.997	0.000
K70.0 Alcoholic fatty liver	0.003	0.997	0.000
X68.9 Unspecified place	0.003	0.997	0.000
D84.9 Immunodeficiency, unspecified	0.003	0.997	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.002	0.997	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.003	0.997	0.000
F52.2 Failure of genital response	0.003	0.997	0.000
X84 Intentional self-harm by unspecified means	0.002	0.997	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.002	0.997	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.003	0.997	0.000
K70.1 Alcoholic hepatitis	0.002	0.997	0.000
C81.9 Hodgkin's disease, unspecified	0.003	0.997	0.000
D81.9 Combined immunodeficiency, unspecified	0.002	0.997	0.000
D81.8 Other combined immunodeficiencies	0.002	0.997	0.000
D81.7 Major histocompatibility complex class II deficiency	0.002	0.997	0.000
D81.6 Major histocompatibility complex class I deficiency	0.002	0.997	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.002	0.997	0.000
D81.4 Nezelof's syndrome	0.002	0.997	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.002	0.997	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.002	0.997	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.002	0.997	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.002	0.997	0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.998	0.002
M93.9 Osteochondropathy, unspecified	0.000	0.998	0.002
D82.9 Immunodeficiency associated with major defect, unspecified	0.002	0.998	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.002	0.998	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.002	0.998	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.002	0.998	0.000
D82.2 Immunodeficiency with short-limbed stature	0.002	0.998	0.000
D82.0 Wiskott-Aldrich syndrome	0.002	0.998	0.000
X84.9 Unspecified place	0.002	0.998	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
S70 Superficial injury of hip and thigh	0.002	0.998	0.000
M24.26 Disorder of ligament (Lower leg)	0.002	0.998	0.000
M24.24 Disorder of ligament (Hand)	0.002	0.998	0.000
M24.85 Other specific joint derangements, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.002	0.998	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.002	0.998	0.000
C32.1 Supraglottis	0.002	0.998	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.002	0.998	0.000
M24.2 Disorder of ligament	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
C17.2 Ileum	0.000	0.998	0.002
C18.3 Hepatic flexure	0.000	0.998	0.002
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
D83.8 Other common variable immunodeficiencies	0.002	0.998	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.002	0.998	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.002	0.998	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.002	0.998	0.000
K74.0 Hepatic fibrosis	0.002	0.998	0.000
L43.9 Lichen planus, unspecified	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.002	0.998	0.000
C32.3 Laryngeal cartilage	0.002	0.998	0.000
C32.2 Subglottis	0.002	0.998	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.002	0.998	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.002	0.998	0.000
O23.4 Unspecified infection of urinary tract in pregnancy	0.002	0.998	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.002	0.998	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.002	0.998	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.002	0.998	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.002	0.998	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
M24.82 Other specific joint derangements, not elsewhere classified (Upper arm)	0.002	0.998	0.000
X78.99 Intentional self-harm by sharp object: Unspecified place: During unspecified activity	0.002	0.998	0.000
D82.1 Di George's syndrome	0.002	0.998	0.000
M24.8 Other specific joint derangements, not elsewhere classified	0.002	0.998	0.000
F52.0 Lack or loss of sexual desire	0.002	0.998	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
G04.0 Acute disseminated encephalitis	0.002	0.998	0.000
X68.8 Other specified place	0.002	0.998	0.000
X68.7 Farm	0.002	0.998	0.000
X68.6 Industrial and construction area	0.002	0.998	0.000
X68.5 Trade and service area	0.002	0.998	0.000
X68.4 Street and highway	0.002	0.998	0.000
X68.3 Sports and athletics area	0.002	0.998	0.000
X68.2 School, other institution and public administrative area	0.002	0.998	0.000
X68.1 Residential institution	0.002	0.998	0.000
X68.0 Home	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
O86.2 Urinary tract infection following delivery	0.002	0.998	0.000
M24.25 Disorder of ligament (Pelvic region and thigh)	0.002	0.998	0.000
O86.4 Pyrexia of unknown origin following delivery	0.002	0.998	0.000
M24.88 Other specific joint derangements, not elsewhere classified (Other)	0.002	0.998	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.002	0.998	0.000
G04.1 Tropical spastic paraplegia	0.002	0.998	0.000
X84.8 Other specified place	0.002	0.998	0.000
X84.7 Farm	0.002	0.998	0.000
X84.6 Industrial and construction area	0.002	0.998	0.000
X84.5 Trade and service area	0.002	0.998	0.000
X84.4 Street and highway	0.002	0.998	0.000
X84.3 Sports and athletics area	0.002	0.998	0.000
X84.2 School, other institution and public administrative area	0.002	0.998	0.000
X84.1 Residential institution	0.002	0.998	0.000
X84.0 Home	0.002	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
S32.50 Fracture of pubis (closed)	0.002	0.998	0.000
D83.9 Common variable immunodeficiency, unspecified	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.002	0.998	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
M24.23 Disorder of ligament (Forearm)	0.002	0.998	0.000
F45.8 Other somatoform disorders	0.002	0.998	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.998	0.002
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.002	0.998	0.000
O86 Other puerperal infections	0.002	0.998	0.000
Z41 Procedures for purposes other than remedying health state	0.000	0.998	0.002
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.998	0.002
X83.9 Unspecified place	0.002	0.998	0.000
O86.8 Other specified puerperal infections	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
K74 Fibrosis and cirrhosis of liver	0.002	0.998	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.002	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.7 Excessive sexual drive	0.002	0.998	0.000
F52.6 Nonorganic dyspareunia	0.002	0.998	0.000
F52.5 Nonorganic vaginismus	0.002	0.998	0.000
F52.4 Premature ejaculation	0.002	0.998	0.000
F52.3 Orgasmic dysfunction	0.002	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.002	0.998	0.000
O23.5 Infections of the genital tract in pregnancy	0.002	0.998	0.000
S70.7 Multiple superficial injuries of hip and thigh	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
M24.29 Disorder of ligament (Site unspecified)	0.002	0.998	0.000
M24.28 Disorder of ligament (Other)	0.002	0.998	0.000
M24.22 Disorder of ligament (Upper arm)	0.002	0.998	0.000
M24.20 Disorder of ligament (Multiple sites)	0.002	0.998	0.000
M24.84 Other specific joint derangements, not elsewhere classified (Hand)	0.002	0.998	0.000
T40.2 Other opioids	0.001	0.998	0.001
X69.0 Home	0.002	0.998	0.000
M24.21 Disorder of ligament (Shoulder region)	0.002	0.998	0.000
M43.02 Spondylolysis (Cervical region)	0.002	0.998	0.000
K74.6 Other and unspecified cirrhosis of liver	0.002	0.998	0.000
M43.0 Spondylolysis	0.002	0.998	0.000
X83.8 Other specified place	0.002	0.998	0.000
X83.7 Farm	0.002	0.998	0.000
X83.6 Industrial and construction area	0.002	0.998	0.000
X83.5 Trade and service area	0.002	0.998	0.000
X83.4 Street and highway	0.002	0.998	0.000
X83.3 Sports and athletics area	0.002	0.998	0.000
X83.2 School, other institution and public administrative area	0.002	0.998	0.000
X83.1 Residential institution	0.002	0.998	0.000
X83.0 Home	0.002	0.998	0.000
F50 Eating disorders	0.002	0.998	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.002	0.998	0.000
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
F50.9 Eating disorder, unspecified	0.002	0.998	0.000
I70.0 Atherosclerosis of aorta	0.002	0.998	0.000
F51 Nonorganic sleep disorders	0.002	0.998	0.000
M43.06 Spondylolysis (Lumbar region)	0.002	0.998	0.000
X61.9 Unspecified place	0.002	0.998	0.000
X61.8 Other specified place	0.002	0.998	0.000
X61.0 Home	0.002	0.998	0.000
X61.7 Farm	0.002	0.998	0.000
X61.6 Industrial and construction area	0.002	0.998	0.000
X61.5 Trade and service area	0.002	0.998	0.000
X61.4 Street and highway	0.002	0.998	0.000
X61.3 Sports and athletics area	0.002	0.998	0.000
X61.2 School, other institution and public administrative area	0.002	0.998	0.000
X61.1 Residential institution	0.002	0.998	0.000
X64.9 Unspecified place	0.002	0.998	0.000
X64.0 Home	0.002	0.998	0.000
X64.8 Other specified place	0.002	0.998	0.000
X64.7 Farm	0.002	0.998	0.000
X64.6 Industrial and construction area	0.002	0.998	0.000
X64.5 Trade and service area	0.002	0.998	0.000
X64.4 Street and highway	0.002	0.998	0.000
X64.3 Sports and athletics area	0.002	0.998	0.000
X64.2 School, other institution and public administrative area	0.002	0.998	0.000
X64.1 Residential institution	0.002	0.998	0.000
X66.9 Unspecified place	0.002	0.998	0.000
X66.8 Other specified place	0.002	0.998	0.000
X66.7 Farm	0.002	0.998	0.000
X66.6 Industrial and construction area	0.002	0.998	0.000
X66.5 Trade and service area	0.002	0.998	0.000
X66.4 Street and highway	0.002	0.998	0.000
X66.3 Sports and athletics area	0.002	0.998	0.000
X66.2 School, other institution and public administrative area	0.002	0.998	0.000
X66.1 Residential institution	0.002	0.998	0.000
X66.0 Home	0.002	0.998	0.000
X70.8 Other specified place	0.002	0.998	0.000
X70.9 Unspecified place	0.002	0.998	0.000
X70.7 Farm	0.002	0.998	0.000
X70.6 Industrial and construction area	0.002	0.998	0.000
X70.5 Trade and service area	0.002	0.998	0.000
X70.4 Street and highway	0.002	0.998	0.000
X70.3 Sports and athletics area	0.002	0.998	0.000
X70.2 School, other institution and public administrative area	0.002	0.998	0.000
X70.1 Residential institution	0.002	0.998	0.000
X70.0 Home	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations